Leveraging the power of AI and machine learning technologies, researchers co-lead by Dr. Bishoy Morris Faltas, the Gellert Family–John P. Leonard MD Research Scholar in Hematology and Medical Oncology in the division of Hematology & Medical Oncology, has developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy. The model harnesses whole-slide tumor imaging and gene expression analyses in a way that outperforms previous...
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer, thanks to a team of researchers lead by principal investigator Dr. Vered Stearns and co-principal investigator Dr. Tessa Cigler, both in the division of Hematology and Medical Oncology.The grant will enable Weill Cornell Medicine...
Dr. Bishoy M. Faltas, Associate Professor of Medicine, Cell and Development Biology, in the Division of Hematology and Medical Oncology, Gellert Family- John P. Leonard, M.D. Research Scholar, and Chief Research Officer of Englander Institute for Precision Medicine, recently received a 2024 Research Innovation Award from the Bladder Cancer Advocacy Network (BCAN) to support his project using advanced mathematical models, known as bio-digital...
With new NIH funding, Weill Cornell Medicine investigators will explore how alterations to the packaging of DNA that affect gene expression, known as epigenetic changes, influence the trajectory of diffuse large B-cell lymphomas. Credit: ShutterstockA new $12.4 million investigator-initiated Program Project grant co-led by Dr. Leandro Cerchietti, the Richard A. Stratton Associate Professor in the Division of Hematology and Medical Oncology, will support a collaborative, multi-...
A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. These structural changes, which alter patterns of gene activity in a cell, are known as epigenetic changes and can lead to malignancy.The new method, described in a paper published on May 8 in Nature, offers biologists a powerful tool that can be applied in many fields of investigation, from basic...
Dr. John Leonard, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology and interim Chair of the Weill Department of Medicine, was presented with the Lifetime Achievement Award from the Cancer Research & Treatment Fund, Inc. (CR&T) during its 2023 Cancer Survivors Hall of Fame Dinner on Nov. 16. The annual event honors survivors, humanitarians, and medical professionals committed to supporting life-saving research to better treat, prevent and cure cancer,...
Dr. Leonard and colleagues found that rituximab (Rituxan) plus lenalidomide (Revlimid) elicited superior progression-free survival for patients with relapsed/refractory indolent non-Hodgkin’s lymphoma.
Dr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director.
The study analyzed the use of autologous stem cell transplantation (ASCT), a type of bone marrow transplantation that uses a patient’s own cells, and found that the usage of ASCT can be low in some patient settings.
This award was initiated by Dr. Ralph Nachman in 2002 to recognize outstanding research during fellowship training.
